New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - roxithromycin 300mg (based on 100% assay - maize starch quantity will be adjusted); roxithromycin 300mg (based on 100% assay - maize starch quantity will be adjusted) - film coated tablet - 300 mg - active: roxithromycin 300mg (based on 100% assay - maize starch quantity will be adjusted) excipient: colloidal silicon dioxide glucose hyprolose magnesium stearate maize starch opadry white oy-s-58918 poloxamer 188 povidone purified talc purified water   active: roxithromycin 300mg (based on 100% assay - maize starch quantity will be adjusted) excipient: colloidal silicon dioxide glucose hyprolose magnesium stearate maize starch opadry white oy-s-58918 poloxamer 188 povidone purified talc purified water  

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - roxithromycin 150mg - film coated tablet - 150 mg - active: roxithromycin 150mg excipient: colloidal silicon dioxide glucose hypromellose   magnesium stearate maize starch poloxamer povidone propylene glycol purified talc titanium dioxide

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - roxithromycin 300mg - film coated tablet - 300 mg - active: roxithromycin 300mg excipient: colloidal silicon dioxide glucose hyprolose hypromellose magnesium stearate maize starch poloxamer povidone propylene glycol purified talc titanium dioxide

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - roxithromycin 50mg - powder for oral suspension - 50 mg - active: roxithromycin 50mg excipient: arginine carmellose sodium colloidal silicon dioxide orange saccharin sucrose

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - roxithromycin 100mg - tablet - 100 mg - active: roxithromycin 100mg excipient: colloidal silicon dioxide glucose hypromellose   magnesium stearate maize starch poloxamer povidone propylene glycol purified talc titanium dioxide

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - roxithromycin 50mg - tablet - 50 mg - active: roxithromycin 50mg excipient: colloidal silicon dioxide glucose hypromellose   hypromellose phthalate magnesium stearate maize starch poloxamer povidone propylene glycol purified talc

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - roxithromycin 50mg - dispersible tablet - 50 mg - active: roxithromycin 50mg excipient: colloidal silicon dioxide crospovidone strawberry fumaric acid glycyrrhiza glabra macrogol 6000 magnesium stearate methacrylic acid copolymer microcrystalline cellulose purified talc saccharin sodium sodium hydroxide sodium laureth sulfate triethyl citrate

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

hexal pharma (sa) (pty) ltd - tablet - see ingredients - each tablet contains roxithromycin 150,0 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

hexal pharma (sa) (pty) ltd - tablet - see ingredients - each tablet contains roxithromycin 300,0 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - roxithromycin -